Emboline Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $55.4M
Latest Deal Amount
  • Investors
  • 8

Emboline General Information

Description

Developer of an embolic protection catheter designed to offer embolic protection during percutaneous heart valve repair and replacement procedures. The company's catheter provides protection of the arterial bed and circumferentially conforms to a wide range of patient anatomies while the expandable access port accommodates a wide range of procedural devices, enabling medical providers to provide complete protection of the brain and other critical organs by capturing and removing emboli produced during the procedure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 849C Almar Avenue
  • Suite 278
  • Santa Cruz, CA 95060
  • United States
+1 (831) 000-0000

Emboline Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Emboline Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 04-Jun-2021 $55.4M 0000 Completed Clinical Trials - General
3. Later Stage VC (Series C) 11-Feb-2021 000.00 000.00 Completed Clinical Trials - General
2. Later Stage VC (Series B) 19-Apr-2018 $10M $10.1M 0000 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 14-Feb-2012 $60K $60K 00000 Completed Startup
To view Emboline’s complete valuation and funding history, request access »

Emboline Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
To view Emboline’s complete cap table history, request access »

Emboline Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an embolic protection catheter designed to offer embolic protection during percutaneous heart valve repair
Surgical Devices
Santa Cruz, CA
7 As of 2021
0000
00000000000 0000

000000 0

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
00000000 0000000
Santa Rosa, CA
000 As of 0000
0000
0000 0000-00-00
000000&0 0000

00000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000000 0000000
Grand Rapids, MI
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Emboline Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Claret Medical Formerly VC-backed Santa Rosa, CA 000 0000 000000&0 0000
0000000000 0000000 Venture Capital-Backed Grand Rapids, MI 000.00 0000000000 0 000.00
000000000 00000000 Private Equity-Backed Irvine, CA 000 00000 0000000 0000 00000
000 0000000 Corporate Backed or Acquired Maple Grove, MN 00 000000&0
0000000000 0000000 Pending Transaction (VC) Denver, CO 0 000.00 000000 0
You’re viewing 5 of 5 competitors. Get the full list »

Emboline Executive Team (5)

Name Title Board Seat Contact Info
Scott Russell Chief Executive Officer, President & Board Member
Elton Satusky Executive Officer
J.Casey McGlynn Executive Officer
Stephen Kleshinski Vice President, Research & Development
Amir Belson MD Founder, Chairman, Managing Director & Chief Technology Officer
To view Emboline’s complete executive team members history, request access »

Emboline Board Members (6)

Name Representing Role Since
Amir Belson MD Self Founder, Chairman, Managing Director & Chief Technology Officer 000 0000
Eric Xiao Matrix Capital Management Board Member 000 0000
Issam Moussa Emboline Board Member 000 0000
Nicholas Pappas Emboline Board Member 000 0000
Peng Cheng Ph.D SV Tech Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Emboline Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emboline Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GAM Investments Hedge Fund Minority 000 0000 000000 0
Matrix Capital Management Hedge Fund Minority 000 0000 000000 0
AimTop Ventures Venture Capital Minority 000 0000 000000 0
BrilliMedical Venture Capital Minority 000 0000 000000 0
ShangBay Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »